Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target hoisted by HC Wainwright from $82.00 to $92.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. APLS has been the subject of a number of other reports. Wells Fargo & Company downgraded […]
Jacob Asset Management of New York LLC raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 1,017.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,850 shares of the company’s stock after buying an additional 4,416 shares during the quarter. […]
Apellis Pharmaceuticals (NASDAQ:APLS) PT Raised to $60 00 at Wedbush theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Inspire Advisors LLC reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 50.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,115 shares of the company’s stock after selling 6,342 shares during the period. Inspire […]
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong […]